ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,946Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 21

$561K Total Retail Price of All Prescriptions

Rank: 6 out of 21

435 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,362 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 619 502 1 2
LEVOTHYROXINE SODIUM 611 500 2 1
LISINOPRIL 345 268 3 7
AMLODIPINE BESYLATE 296 237 4 8
HYDROCODONE-ACETAMINOPHEN 278 159 S3 5 3
OMEPRAZOLE 244 182 6 4
ATORVASTATIN CALCIUM 213 164 7 19
TRAMADOL HCL 193 150 8 16
METFORMIN HCL 179 127 9 10
HYDROCHLOROTHIAZIDE 175 122 10 14
CRESTOR 171 134 11 33
FUROSEMIDE 166 116 12 5
ZOLPIDEM TARTRATE 159 83 13 21
LOSARTAN POTASSIUM 158 143 14 17
ALENDRONATE SODIUM 156 130 15 27
CITALOPRAM HBR 149 118 16 12
GABAPENTIN 142 112 17 11
NEXIUM 141 69 18 25
POTASSIUM CHLORIDE 137 89 19 6
ATENOLOL 129 121 20 13
METOPROLOL SUCCINATE 128 115 21 20
PRAVASTATIN SODIUM 118 105 22 65
METOPROLOL TARTRATE 103 83 23 15
ALLOPURINOL 102 99 24 23
CYCLOBENZAPRINE HCL 101 45 R 25 43
SERTRALINE HCL 98 58 26 35
TAMSULOSIN HCL 94 93 27 36
DONEPEZIL HCL 80 68 28 32
SYNTHROID 80 75 28 70
LOSARTAN-HYDROCHLOROTHIAZIDE 75 54 30 78
FLUTICASONE PROPIONATE 71 64 31 48
PROAIR HFA 68 44 32 39
PANTOPRAZOLE SODIUM 67 33 33 31
CARVEDILOL 67 65 33 26
WARFARIN SODIUM 65 50 35 9
CLONIDINE HCL 65 41 35 90
NAMENDA 64 64 37 28
CYMBALTA 64 26 37 30
GLIMEPIRIDE 60 41 39 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 31 39 51
DICLOFENAC SODIUM 56 17 41 84
ADVAIR DISKUS 56 28 41 58
SPIRIVA 55 31 43 75
GLYBURIDE 54 30 R 44 79
ENALAPRIL MALEATE 53 40 45 38
FAMOTIDINE 50 46 46 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.